Wiley
Wiley.com
Print this page Share

Malignant Liver Tumors: Current and Emerging Therapies, 3rd Edition

Pierre-Alain Clavien (Editor), Stefan Breitenstein (Deputy Editor), Jacques Belghiti (Associate Editor), Ravi S. Chari (Associate Editor), Josep M. Llovet (Associate Editor), Chung-Mau Lo (Associate Editor), Michael A. Morse (Associate Editor), Tadatoshi Takayama (Associate Editor), Jean-Nicolas Vauthey (Associate Editor)
ISBN: 978-1-4051-7976-8
576 pages
February 2010, Wiley-Blackwell
Malignant Liver Tumors: Current and Emerging Therapies, 3rd Edition (1405179767) cover image
This comprehensive and critical review of current and established treatment modalities for malignant liver tumors is designed to help you sort through the proliferation of competitive approaches and choose the best treatment options for your patient. Dr. Clavien and his contributors consider all the options – radiological, surgical, pharmaceutical, and emerging/novel therapies – and help you find the best single or combined therapy.

Building on the success of the previous edition, this extremely thorough revision:

  • features a new section on Guidelines for Liver Tumors, where you will find specific strategies for treating common liver malignancies; the guidelines were prepared by the Associate Editors and take into account national and international society guidelines
  • reflects actual practice by taking a multidisciplinary approach, with contributions from international experts who have extensive experience with this patient population
  • achieves comprehensive and balanced coverage by having each chapter reviewed by the Editor, Deputy Editor, two Associate Editors, and at least one external reviewer
  • includes 16 new chapters that cover liver anatomy, histologic changes in the liver, epidemiology and natural history of HCC, CCC and colorectal liver metastases, strategies of liver resection, and economic aspects as well as novel therapies
  • facilitates the kind of daily interaction among hepatologists, hepatic surgeons, medical oncologists, radiotherapists, and interventional radiologists that is essential when treating patients with complex liver malignancies

In 44 chapters organized into six major sections, the book covers the full range of liver tumors. The perfect blend of evidence and experience, Malignant Liver Tumors: Current and Emerging Therapies, 3rd Edition, illuminates the path to better patient care.

See More
Contributors, vii

Preface, xi

Acknowledgments, xiii

Abbreviations, xiv

Section 1 Introduction, 1

1 From Promethean to Modern Times, 3
Kuno Lehmann, Stefan Breitenstein, and Pierre-Alain Clavien

2 Hepatic Anatomy and Terminology, 11
Steven M. Strasberg

Section 2 Epidemiology and Diagnosis, 27

Introduction, 29
Chung-Mau Lo

3 Histology and Pathology of Normal and Diseased Liver, 30
Valérie Paradis and Achim Weber

4 Pathology of Primary and Secondary Malignant Liver Tumors, 40
Kay Washington

5 Epidemiology, Etiology, and Natural History of Hepatocellular Carcinoma, 52
Wei-Chen Lee and Miin-Fu Chen

6 Epidemiology, Etiology, and Natural History of Cholangiocarcinoma, 56
Peter Neuhaus, Ulf P. Neumann, and Daniel Seehofer

7 Epidemiology, Etiology, and Natural History of Colorectal Liver Metastases, 64
Robert J. Porte

8 Tumor Markers in Primary and Secondary Liver Tumors, 69
Ketsia B. Pierre and Ravi S. Chari

9 Modalities for Imaging Liver Tumors, 76
Dominik Weishaupt and Thomas F. Hany

Section 3 Systemic and Regional Therapies, 103

Introduction, 105
Ravi S. Chari

10 Systemic Treatment of Hepatobiliary Tumors, 107
Panagiotis Samaras, Michael A. Morse, and Bernhard C. Pestalozzi

11 External Beam Radiation Therapy for Liver Tumors, 122
Rakesh Reddy and A. Bapsi Chakravarthy

12 Internal Radiation Therapy for Liver Tumors, 131
Ahsun Riaz, Laura Kulik, Michael Abecassis, and Riad Salem

13 Transarterial Embolization for Patients with Hepatocellular Carcinoma, 139
Jordi Bruix, Carmen Ayuso, and Maria I. Real

14 Selective Continuous Intra-arterial Chemotherapy for Liver Tumors, 151
Fidel D. Huitzil-Melendez, Stefan Breitenstein, and Nancy Kemeny

15 Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion, 164
Charles K. Heller, III, James F. Pingpank, and Steven K. Libutti

Section 4 Resection, Ablation or Transplantation for Liver Tumors, 173

Introduction, 175
Jean-Nicolas Vauthey and Tadatoshi Takayama

16 Liver Resection of Primary Tumors: Hepatocellular Carcinoma, Cholangiocarcinoma, and Gallbladder Cancer, 177
Tadatoshi Takayama and Masatoshi Makuuchi

17 Liver Resection of Colorectal Liver Metastases, 192
Daria Zorzi, Yun Shin Chun, and Jean-Nicolas Vauthey

18 Laparoscopic Liver Resection, 203
Luca Viganò and Daniel Cherqui

19 Repeat Resection for Liver Tumors, 216
Mickael Lesurtel and Henrik Petrowsky

20 Cryoablation of Liver Tumors, 227
Sivakumar Gananadha and David L. Morris

21 Thermal Ablation of Liver Tumors by Radiofrequency, Microwave, and Laser Therapy, 244
M. B. Majella Doyle and David C. Linehan

22 Ethanol and Other Percutaneous Injection Modalities in the Treatment of Liver Tumors, 266
Michael A. Heneghan and Andrew D. Yeoman

23 Transplantation for Liver Tumors, 281
François Durand, Claire Francoz, and Jacques Belghiti

24 Preventing Recurrence of Hepatocellular Carcinoma after Curative Resection, 296
Stefan Breitenstein, Dimitris Dimitroulis, and Beat Müllhaupt

Section 5 Guidelines for Liver Tumor Treatment, 305

Introduction, 307
Stefan Breitenstein and Pierre-Alain Clavien

25 Strategies for Safer Liver Surgery, 308
Philipp Dutkowski, Olivier de Rougemont, and Pierre-Alain Clavien

26 Hepatocellular Carcinoma, 317
Tadatoshi Takayama

27 Cholangiocarcinoma, 324
Jacques Belghiti and Charles B. Rosen

28 Gallbladder Cancer, 333
Juan Hepp and Chung-Mau Lo

29 Colorectal Liver Metastases, 342
Phuong L. Doan, Jean-Nicolas Vauthey, Martin Palavecino, and Michael A. Morse

Section 6 Emerging Therapies, 347

Introduction, 349
Michael A. Morse and Josep M. Llovet

30 Viral-Based Therapies for Primary and Secondary Liver Cancer, 352
Menghua Dai, Lorena Gonzalez, and Yuman Fong

31 Signaling Pathways and Rationale for Molecular Therapies in Hepatocellular Carcinoma, 368
Augusto Villanueva, Clara Alsinet, and Josep M. Llovet

32 Novel Therapies Targeted at Signal Transduction in Liver Tumors, 382
Fidel D. Huitzil-Melendez, Ghassan K. Abou-Alfa, and Michael A. Morse

33 Induction of Apoptosis in Liver Tumors, 393
Markus Selzner and Pierre-Alain Clavien

34 Antiangiogenic Agents for Liver Tumors, 400
Mathijs Vogten, Emile E. Voest, and Inne H.M. Borel Rinkes

35 Integrative Oncology: Alternative and Complementary Treatments, 414
Barrie R. Cassileth and Jyothirmai Gubili

Section 7 Special Tumors, Population, and Special Considerations, 421

Introduction, 423
Stefan Breitenstein and Pierre-Alain Clavien

36 Liver Metastases from Endocrine Tumors, 424
Clayton D. Knox and C. Wright Pinson

37 Uncommon Primary and Metastatic Liver Tumors, 439
Stefan Breitenstein, Ashraf Mohammad El-Badry, and Pierre-Alain Clavien

38 Liver Tumors in Special Populations, 454
Tadahiro Uemura, Akhtar Khan, and Zakiyah Kadry

39 Malignant Liver Tumors in Children, 475
Xavier Rogiers and Ruth De Bruyne

40 Liver Tumors in Asia, 487
Norihiro Kokudo, Sumihito Tamura, and Masatoshi Makuuchi

41 Liver Tumors in South America, 500
Lucas McCormack and Eduardo de Santibañes

42 Liver Tumors in Africa, 509
Michael C. Kew

43 Anesthetic Management of Liver Surgery, 519
Marco P. Zalunardo

44 Qualitative and Economic Aspects of Liver Surgery, 531
René Vonlanthen, Ksenija Slankamenac, and Christian Ernst

Index, 539

See More
Editor-in-Chief:
Pierre-Alain Clavien

Department of Visceral and Transplant Surgery, University Hospital Zurich, Switzerland

Associate Editors:
Tadatoshi Takayama
, Second Department of Surgery, Faculty of Medicine, University of Tokyo, Japan

CM Lo, Liver Transplant Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong

R. Chari, Associate Professor of Surgery and Cancer Biology, Division Chief of Hepatobillary Surgery and Liver Transplantation, Staff Surgeon, Veterans Affairs Medical Center, Vanderbilt University Medical Center, Nashville, USA

M. Morse, Associate Professor, Duke University Medical School, Durham, USA

J. Llovet, Barcelona-Clínic Liver Cancer Group, Liver Unit, Institut d'Investigacions Biomédiques August Pi I Sunyer, Hospital Clínic, University of Barcelona, Catalonia, Spain

See More

“This book is a worthy update. A significant amount of material has been added, including the new section. It definitely justifies replacing the old edition and will be a valuable resource for physicians of all disciplines involved in the care of these patients.”  (Doody’s, 23 March 2012)

"The third edition of Malignant Liver Tumors is well written with broad coverage of primary and metastatic liver tumors with a particular emphasis on current and emerging treatment. Consisting of up-to-date and comprehensive reviews on management of hepatic neoplasms, this book will not only be instructive to liver surgeons, trainees, and fellows, but also be valuable to hepatologists, oncologists, and interventional radiologists who form the multidisciplinary team to manage patients with these tumors." (Gastroenterological, 1 March 2011)

 

See More

Related Titles

Back to Top